Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -43,755 | -81,714 | N/A | N/A |
| Depreciation Amortization | -104 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -426 | 1,313 | N/A | N/A |
| Other Working Capital | 6,462 | 1,061 | N/A | N/A |
| Other Operating Activity | 2,196 | 74,715 | 0 | 0 |
| Operating Cash Flow | $-35,627 | $-4,625 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -71,513 | N/A | N/A | N/A |
| Net Acquisitions | N/A | -5,000 | N/A | N/A |
| Investing Cash Flow | $-71,513 | $-5,000 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 95,988 | 8 | N/A | N/A |
| Other Financing Activity | 0 | 84,999 | 0 | 0 |
| Financing Cash Flow | $95,988 | $85,007 | $N/A | $N/A |
| Beginning Cash Position | 76,000 | 618 | N/A | N/A |
| End Cash Position | 64,848 | 76,000 | N/A | N/A |
| Net Cash Flow | $-11,152 | $75,382 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -35,627 | -4,625 | N/A | N/A |
| Free Cash Flow | -35,627 | -4,625 | 0 | 0 |